Try our Advanced Search for more refined results
Searching dockets in Oyster Point Pharma Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Letter
Letter from Oyster Point Pharma, Inc. re 15 Application for Clerk's Order to Ext Answer/Proposed Order. (MILLER, GREGORY)
Text Order ~Util - Set Hearings
TEXT ORDER-- The Court is in receipt of the parties' joint request for an adjournment of the initial scheduling conference currently scheduled for July 2, 2026. (ECF No. 16). The request is GRANTED in part. The initial pretrial scheduling conference is rescheduled to July 17, 2026 at 10:30 a.m. Microsoft Teams login information will be provided. The parties shall file a proposed joint discovery plan no later than five (5) business days before the scheduled initial conference. The Court's form joint discovery plan can be found here. So Ordered by Magistrate Judge Stacey D. Adams on 6/25/2026. (JB)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.